Elite Pharmaceuticals Inc (ELTP)

[WeeZuhl]

extended-release generic drug product in a class of medications called dopamine agonists

Haven't sunk my teeth into the PR yet, but off the top of my head, the only two dopamine agonists that I am aware of that are approved as extended release tablets are Requip ER and Mirapex ER. I am surprised either one of those drugs would have only $12M annual sales, but I have no idea. I am sure the IR version of Requip should be hundreds of millions, but the ER version is not formally approved for restless legs, so maybe it is much less. The other drugs in that class are either patches or only approved as immediate release, as far as I know.

.